We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
-$5.82B
Cap. Flow
+$1.91B
Cap. Flow %
4.16%
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$127M
2
CI icon
Cigna
CI
+$54M
3
CVS icon
CVS Health
CVS
+$38.8M
4
MPC icon
Marathon Petroleum
MPC
+$28.9M
5
FANG icon
Diamondback Energy
FANG
+$19M

Sector Composition

Rank Sector Weight
1 Technology 16.95%
2 Financials 15.85%
3 Healthcare 14.41%
4 Consumer Discretionary 10.13%
5 Industrials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRU icon
151
Prudential Financial
PRU
$42.6B
$59.6M 0.13%
731,215
+6,940
+1% +$639K
EW icon
152
Edwards Lifesciences
EW
$50B
$58.6M 0.13%
1,147,965
-47,226
-4% -$2.39M
ETN icon
153
Eaton
ETN
$150B
$57.9M 0.13%
842,900
-11,564
-1% -$865K
HPQ icon
154
HP
HPQ
$24.6B
$57.7M 0.13%
2,819,884
-10,282
-0.4% -$240K
DAL icon
155
Delta Air Lines
DAL
$58.3B
$57.4M 0.12%
1,150,588
+15,028
+1% +$818K
BAX icon
156
Baxter International
BAX
$13.8B
$57.4M 0.12%
871,432
+21,951
+3% +$1.47M
SHW icon
157
Sherwin-Williams
SHW
$83.7B
$56.9M 0.12%
434,166
+5,184
+1% +$699K
ATVI
158
DELISTED
Activision Blizzard
ATVI
$56.7M 0.12%
1,217,436
+8,117
+0.7% +$486K
ROP icon
159
Roper Technologies
ROP
$38.5B
$56.2M 0.12%
210,986
+3,549
+2% +$1M
FISV
160
Fiserv Inc
FISV
$28.8B
$56.2M 0.12%
764,450
-50,387
-6% -$3.9M
RHT
161
DELISTED
Red Hat Inc
RHT
$56M 0.12%
318,871
-10,064
-3% -$1.59M
REGN icon
162
Regeneron Pharmaceuticals
REGN
$77.4B
$55M 0.12%
147,235
+1,104
+0.8% +$404K
MAR icon
163
Marriott International
MAR
$99B
$54.7M 0.12%
503,504
-7,629
-1% -$876K
SYY icon
164
Sysco
SYY
$40.6B
$54.4M 0.12%
867,467
+8,918
+1% +$601K
YUM icon
165
Yum! Brands
YUM
$43.3B
$53.5M 0.12%
581,568
-3,984
-0.7% -$356K
F icon
166
Ford
F
$59.3B
$52.7M 0.11%
6,883,660
+48,029
+0.7% +$428K
SRE icon
167
Sempra
SRE
$58.6B
$52.6M 0.11%
972,072
+2,920
+0.3% +$166K
DG icon
168
Dollar General
DG
$28.1B
$52.6M 0.11%
486,399
-27,974
-5% -$3.03M
HCA icon
169
HCA Healthcare
HCA
$85.7B
$51.9M 0.11%
417,099
+6,676
+2% +$896K
ADI icon
170
Analog Devices
ADI
$179B
$51.9M 0.11%
604,312
-2,440
-0.4% -$211K
PAYX icon
171
Paychex
PAYX
$41.4B
$51.7M 0.11%
794,093
-29,965
-4% -$2.03M
APH icon
172
Amphenol
APH
$197B
$51.7M 0.11%
2,552,664
-107,172
-4% -$2.3M
AMAT icon
173
Applied Materials
AMAT
$398B
$51.6M 0.11%
1,576,584
-31,737
-2% -$1.09M
KMI icon
174
Kinder Morgan
KMI
$70.5B
$51.5M 0.11%
3,346,039
+28,176
+0.8% +$477K
ORLY icon
175
O'Reilly Automotive
ORLY
$72.4B
$51.3M 0.11%
2,235,735
-69,990
-3% -$1.59M

Similar funds

RhumbLine Advisers's Q4 2018 Portfolio in Review

As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.

  • RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
  • RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
  • RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
  • RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
  • RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
  • RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.